← FDA Drug Approvals (Drugs@FDA)

DAPTOMYCIN

ANDA · Abbreviated New Drug Application (Generic) · Sponsor: FRESENIUS KABI USA · Approved 2018-04-11

Drug application

FDA Application #

ANDA206077

Application type

Abbreviated New Drug Application (Generic)

Brand name

DAPTOMYCIN

Generic name

DAPTOMYCIN

Active ingredients

DAPTOMYCIN

Dosage form

POWDER

Route

INTRAVENOUS

Marketing status

Prescription

Sponsor

FRESENIUS KABI USA

Manufacturer

Fresenius Kabi USA, LLC

First approval

2018-04-11

Source

Authoritative

Drugs@FDA application overview

Machine

JSON-LD · Markdown